Back to Agenda
Next Generation Clinical Trial Quality Assurance Using Advanced Analytics
Session Chair(s)
Jennifer Emerson, MPH, RN, PMP
Head Quality Analytics & Risk Management
Boehringer Ingelheim, Germany
See how different pharmaceutical companies use advanced analytics to augment traditional quality assurance methods, hear the Regulators’ perspective on use of innovative quality assurance methods.
Learning Objective : Identify the different methods that are available to assure the quality of clinical trials that go beyond traditional on-site auditing; Discuss how different companies have applied analytics methods and their impact on clinical trial quality assurance.
Speaker(s)
SCORE - Next Generation Clinical Trial Quality Assurance Using Advanced Analytics
Jamie Bridges, MPH
Merck Sharp & Dohme LLC , United States
Executive Director, Clinical Quality Assurance
Critical to Quality Assessment Report - Next Generation Clinical Trial Quality Assurance Using Advanced Analytics
Kiernan Trevett, MSC
Genentech, A Member of the Roche Group, United States
Quality Policy Lead
Regulators Perspective Next Generation Clinical Trial Quality Assurance Using Advanced Analytics
Representative Invited
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Panelist
Representative Invited
FDA, United States
Have an account?